Results 171 to 180 of about 3,550,326 (312)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy for locally advanced rectal cancer: 3-year survival from a phase 2 study. [PDF]

BMC Med
Lin Z, Zhang P, Cai M, Li G, Liu T, Cai K, Wang J, Liu J, Liu H, Zhang W, Gao J, Wu C, Wang L, Wang Z, Hou Z, Kou H, Tao K, Zhang T.   +17 more
europepmc   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

Molecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Minimally invasive diagnostic and therapeutic surgery for an intra-abdominal desmoid tumor: A case report

Gynecologic Oncology Reports, 2020
Makiko Omi, Hiroyuki Kanao, Yoichi Aoki, Sanshiro Okamoto, Nobuhiro Takeshima   +4 more
doaj   +1 more source

P361: EARLY MEASURABLE RESIDUAL DISEASE ANALYSIS IS ONLY PREDICTIVE OF SURVIVAL OUTCOMES AFTER TWO CYCLES OF TREATMENT IN ADULTS WITH B-LYMPHOBLASTIC LEUKEMIA RECEIVING HYPER-CVAD INDUCTION.

HemaSphere, 2022
R. Nedumannil, D. Ritchie, A. Bajel, A. P. Ng, S. J. Harrison, D. Westerman   +5 more
doaj   +1 more source

Robot-Assisted <i>versus</i> Open Radical Prostatectomy in the Treatment of Localized Prostate Cancer: 3-Year Results from a Prospective Cohort Study. [PDF]

World J Mens Health
Jeong CW, Yoo SH, Han JH, Jeong SH, Yuk HD, Ku JH, Kim HH, Kwak C.   +7 more
europepmc   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Development of an ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography-based visceral pleural invasion prediction index in peripheral subpleural non-small cell lung cancer ≤3 cm. [PDF]

Quant Imaging Med Surg
Zhang H, Lei B, Wang L, He X, Jia S, Huang G, Liu L, Xie W.   +7 more
europepmc   +1 more source

High-grade serous ovarian cancer 3 years after bilateral salpingectomy: A case report. [PDF]

Mol Clin Oncol, 2017
Sato E, Nakayama K, Ishikawa M, Nakamura K, Ishibashi T, Kyo S.   +5 more
europepmc   +1 more source

Expression of TRAG‐3 in breast cancer [PDF]

International Journal of Cancer, 2003
Yu-Zhang, Wu, Ting-Ting, Zhao, Bing, Ni, Li-Yun, Zou, Hong-Li, Liu, Bo, Zhu   +5 more
openaire   +2 more sources

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

Molecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak, Iva Staniczková Zambo, Matěj Přikryl, Peter Múdry, Danica Zapletalová, Jarmila Navrátilová, Jiří Navrátil, Jan Šmarda, Liudmyla Drobot, Petr Beneš, Lucia Knopfová   +10 more
wiley   +1 more source